Free Trial
NYSEAMERICAN:MYO

Myomo (MYO) Stock Price, News & Analysis

Myomo logo
$3.96
+0.13 (+3.39%)
(As of 11/5/2024 ET)

About Myomo Stock (NYSEAMERICAN:MYO)

Key Stats

Today's Range
$3.80
$4.05
50-Day Range
N/A
52-Week Range
$1.41
$5.64
Volume
183,033 shs
Average Volume
328,504 shs
Market Capitalization
$119.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.63
Consensus Rating
Buy

Company Overview

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Myomo Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
39th Percentile Overall Score

MYO MarketRank™: 

Myomo scored higher than 39% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Myomo has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Myomo has only been the subject of 2 research reports in the past 90 days.

  • Read more about Myomo's stock forecast and price target.
  • Earnings Growth

    Earnings for Myomo are expected to grow in the coming year, from ($0.17) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Myomo is -15.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Myomo is -15.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Myomo has a P/B Ratio of 11.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.88% of the float of Myomo has been sold short.
  • Short Interest Ratio / Days to Cover

    Myomo has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Myomo has recently increased by 12.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Myomo does not currently pay a dividend.

  • Dividend Growth

    Myomo does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.88% of the float of Myomo has been sold short.
  • Short Interest Ratio / Days to Cover

    Myomo has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Myomo has recently increased by 12.61%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Myomo this week, compared to 1 article on an average week.
  • Search Interest

    3 people have searched for MYO on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 2 people have added Myomo to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Myomo insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $8,136.00 in company stock.

  • Percentage Held by Insiders

    Only 4.54% of the stock of Myomo is held by insiders.

  • Percentage Held by Institutions

    44.99% of the stock of Myomo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Myomo's insider trading history.
Receive MYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Myomo and its competitors with MarketBeat's FREE daily newsletter.

MYO Stock News Headlines

Could TSLA reach $500 a share? Free ebook says it’s possible.
Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.
Hain Celestial: A Buy Rating Amidst Strategic Focus and Growth Potential
Lake Street Keeps Their Buy Rating on Myomo (MYO)
Myomo (MYO) Gets a Buy from Craig-Hallum
See More Headlines

MYO Stock Analysis - Frequently Asked Questions

Myomo's stock was trading at $4.74 at the beginning of the year. Since then, MYO stock has decreased by 16.5% and is now trading at $3.96.
View the best growth stocks for 2024 here
.

Myomo, Inc. (NYSEAMERICAN:MYO) posted its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.04. The firm had revenue of $7.52 million for the quarter, compared to analysts' expectations of $7.30 million. Myomo had a negative net margin of 44.75% and a negative trailing twelve-month return on equity of 93.10%.

Myomo's top institutional shareholders include Rosalind Advisors Inc. (9.99%), Essex Investment Management Co. LLC (2.97%), GSA Capital Partners LLP (0.34%) and AlphaCentric Advisors LLC (0.17%). Insiders that own company stock include Paul R Gudonis, David A Henry, Thomas F Kirk, Harry Kovelman, Milton Mayo Morris, Micah Mitchell and Thomas Aloysius Jr Crowley.
View institutional ownership trends
.

Shares of MYO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Myomo investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Meta Platforms (META), Jabil (JBL), Novo Nordisk A/S (NVO) and Adobe (ADBE).

Company Calendar

Last Earnings
8/06/2024
Today
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NYSEAMERICAN:MYO
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.63
High Stock Price Target
$8.50
Low Stock Price Target
$7.00
Potential Upside/Downside
+93.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-8,150,000.00
Pretax Margin
-43.26%

Debt

Sales & Book Value

Annual Sales
$19.24 million
Book Value
$0.34 per share

Miscellaneous

Free Float
28,854,000
Market Cap
$119.11 million
Optionable
Not Optionable
Beta
1.56
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NYSEAMERICAN:MYO) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners